GENEGENETIC TECHNOLOGIES LTD

Nasdaq genetype.com


$ 1.94 $ 0.05 (2.65 %)    

Thursday, 30-May-2024 15:45:17 EDT
QQQ $ 454.82 $ -6.82 (-1.51 %)
DIA $ 398.57 $ 0.43 (0.11 %)
SPY $ 530.36 $ -4.73 (-0.9 %)
TLT $ 91.26 $ -0.10 (-0.12 %)
GLD $ 225.37 $ -0.86 (-0.4 %)
$ 1.94
$ 1.94
$ 0.00 x 0
$ 2.18 x 100
$ 1.94 - $ 1.95
$ 1.67 - $ 25.75
60,996
na
1.49M
$ 1.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 gtg-launches-genetype-a-novel-comprehensive-risk-assessment-test-that-covers-100-of-women-at-risk-of-developing-breast-and-ovarian-cancer

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetic-technologies-and-wellworks-for-you-sign-b2b-sales--marketing-deal-covering-750-employer-groups-and-2m-us-employees

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, &ldquo, Company&rdquo, , &ldquo, GTG&rdquo, )), a global ...

 genetic-technologies-announces-2m-registered-direct-offering-of-1m-ads-at-a-price-of-2ads

Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, ", Company", , ", GTG", , or ", Genetic Technologies&#...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION